Cancer biomarker discovery: Lectin-based strategies targeting glycoproteins

Disease Markers

Volumn 33, Issue 1, 2012, Pages 1-10

  Clark, David ^a   Mao, Li ^a  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

biomarkers; glycoproteins; glycosylation; lectin affinity; Lectins

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CA 27-29 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FIBRIN; GLYCOPROTEIN; LECTIN; PROGESTERONE RECEPTOR; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER SCREENING; DISEASE COURSE; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 84862902217     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2012-0904     Document Type: Review

References (46)

1. K.L Abbot, J. Lim, L. Wells, B.B. Benigno, J.F. McDonald, M. Pierce, Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometroid ovarian cancer patients by glycoproteomic analysis. Proteomics 10 (2010), 470-481.
2. Y.H. Ah, Y. Kim, E.S. Ji, J.Y. Lee, J. Jung, J.H. Ko, J.S. Yoo, Comparative quantitation of aberrant glycoforms by lectinbased glycoprotein enrichment coupled withmultiple-reaction monitoring mass spectrometry. Anal Chem 82 (2010), 4441-4447.
3. H.J. An, S.R. Kronewitter, M.L A de Leoz, C.B. Lebrilla, Glycomics and disease markers. Current Opinion in Chemical Biology 13 (2009), 601-607.
4. Biomarkers Definitions Working Group, Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 69 (2001), 89-95.
5. C.D. Calvano, C.G. Zambonin, O.N. Jensen, Assessment of lectin and HILIC based enrichment protocols for characterization of serum glycoproteins bymass spectrometry. Proteomics 71 (2008), 304-317.
6. S. Chen, T. Zheng, M.R. Shortreed, C. Alexander, L.M. Smith, Analysis of cell surface carbohydrate expression patterns in normal and tumorigenic human breast cell lines using lectin arrays. Anal Chem 79 (2007), 5698-5702.
7. E.P. Diamandis, Cancer biomarkers: can we turn recent failures into success? J Natl Cancer Inst 102 (2010), 1462-1467.
8. P.M. Drake, W. Cho, B. Li, A. Prakobphol, E. Johansen, N.L. Anderson, F.E. Regnier, B.W. Gibson, S.J. Fisher, Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin Chem 56 (2010), 223-236.
9. S. Feng, N. Yang, S. Pennathur, S. Goodison, D.M. Lubman, Enrichment of glycoproteins using nanoscale chelating concanavalin a monolithic capillary chromatography. Anal Chem 81 (2009), 3776-3783.
10. G.W. Hart and R.J. Copeland, Glycomics hits the big time. Cell 143 (2010), 672-676.
11. P. Hongsachart, R. Huang-Liu, S. Sinchaikul, F. Pan, S. Phutrakut, Y. Chaung, C. Yu, S. Chen, Glycoproteomic analysis ofWGA-bound glycoprotein biomarkers in sera from patient with lung adenocarcinmoa. Electrophoresis 30 (2009), 1206-1220.
12. G.L. Hortin, D. Sviridov, The dynamic range problem in the analysis of the plasma proteome. Proteomics 73 (2010), 629-636.
13. J.M. Jacobs, J.N. Adkins, W. Qian, T. Liu, Y. Shen, D.G. Camp II, R.D. Smith, Utilizing human blood plasma for proteomic biomarker discovery. J Proteome Res (2005), 1073-1085.
14. S. Khleif, J.H. Doroshow, W.N. Hait, AACR-FDA-NCI cancer biomarkers collbaborative consensus report: advancing the use of biomarkers in cancer drug development. Clin Can Res 16 (2010), 3299-3318.
15. E.H. Kim and D.E. Misek, Glycoproteomics-based identification of cancer biomarkers. Int J Proteomics (2011), 84-94.
16. M. Kullolli, W.S. Hancock, M. Hincapie, Preparation of a high-performance multi-lectin affinity chromatography (HPM-LAC) adsorbent for the analysis of human plasma glycoproteins. J Sep Sci 31 (2008), 2733-2739.
17. A. Larkin and B. Imperiali, The expanding horizons of asparagine-linked glycosylation. Biochemistry 50 (2011), 4411-4426.
18. H. Lee, K. Na, E. Choi, K.S. Kim, H. Kim, Y. Paik, Simple method for quantitative anaysis of n-linked glycoproteins in hepatocellular carcinoma specimens. J Proteome Res 9 (2010), 308-318.
19. Y. Li, S. Tao, G.S. Bova, A.Y. Liu, D.W. Chan, H. Zhu, H. Zhang, Detection and verification of glycosylation patterns of glycoproteins from clinical specimens using lectin microarrays and lectin-based immunosrobent assays. Anal. Chem. 83 (2011), 8509-8516.
20. D. Loo, A. Jones, M.M. Hill, Lectin magnetic bead array for biomarker discovery. J Proteome Res 9 (2010), 5496-5500.
21. J.A. Ludwig and J.N. Weinstein, Biomarkers in cancer staging, prognosis and treatment selection. Nature Reviews Cancer 5 (2005), 845-856.
22. S. Makawita and E.P. Diamandis, The bottleneck in the cancer biomarker pipeline and protein quantitation through massspectrometry-based approaches: current strategies for candidate verification. Clin Chem 56 (2010), 212-222.
23. M. Mann and N.L. Kelleher, Precision proteomics: The case for high resolution and highmass accuracy. PNAS 105 (2008), 18132-18138.
24. D.L. Meany and D.W. Chan, Aberrant glycosylation associated with enzymes as cancer biomarkers. Clin Proteomics 8 (2011), 7-21.
25. N. Mortezai, S. Harder, C. Schnabel, E. Moors, M. Gauly, H. Schluter, C. Wagener, F. Buck, Tandem affinity depletion: a combination of affinity fractionation and immunoaffinity depletion allows the detection of low-abundance components in the complex proteomes of body fluids. J Proteome Res 9 (2010), 6126-6134.
26. T.A. Neuber and P. Tempst, Super-SILAC for tumors and tissues. Nature Methods 7 (2010), 361-362.
27. S. Ogino, J. Galon, C.S. Fuchs, G. Dranoff, Cancer immunology-analysis of host and tumor factors for personalized medicine. Nat Rev Clin Oncol (2011), doi: 10.1038/nrclinonc. 2011.122.
28. S. Park, S. Lee, N. Kawasaki, S. Itoh, K. Kang, S.H. Ryu, N. Hashii, J. Kim, J. Kim, J.H. Kim, α1-3/4 fucosylation at Asn 241 of β-haptoglobin is a novel marker for colon cancer: a combinatorial approach for development of glycan biomarkers. Int J Cancer (2011), doi: 10.1002/ijc.26288.
29. T.H. Patwa, J. Zhao, M.A. Anderson, D.M. Simeone, D.M. Lubman Screening of glycosylation patterns in serum using natural glycoproteinmicroarrays andmulti-lectin fluorescence detection. Anal Chem 78 (2006), 6411-6421.
30. T. Patwa, C. Li, D.M. Simeone, D.M. Lubman, Glycoprotein analysis using protein microarrays andmass spectrometry. Mass Spectrometry Reviews 29 (2010), 830-844.
31. M.S. Pepe, R. Etzioni, Z. Feng, J.D. Potter, M.L. Thompson, M. Thornquist, M. Winget, Y. Yasui, Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93 (2001), 1054-1061.
32. K.T. Pilobello, L. Krishnamoorthy, D. Slawek, L.K. Mahal, Development of a lectin microarray for the rapid analysis of protein glycopatterns. ChemBio Chem 6 (2005), 985-989.
33. T. Plavina, E. Wakshull, W.S. Hancock, M. Hincapie, Combination of abundant protein depletion and multi-lectin affinity chromatography (M-LAC) for plasma protein biomarker discovery. J Proteome Res (2007), 662-671.
34. C.A. Reis, H. Osorio, L. Silva, C. Gomes, L. David, Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol (2010), 322-329.
35. J.M. Rhea and R.J. Molinaro, Cancer Biomarkers: Surviving the journey from bench to bedside. MLO Med Lab Obs 43 (2011), 10-18.
36. R. Schiess, B. Wollscheid, R. Aebersold, Targeted proteomic strategy for clinical biomarker discovery. Mol Oncol 3 (2009), 33-44.
37. V. Shetty, Z. Nickens, P. Shah, G. Sinnathamby, O.J. Semmes, R. Philip, Investigation of sialylation aberration in n-linked glycoproteins by lectin and tandem labeling (LTL) quantitative proteomics. Anal Chem 82 (2010), 9201-9210.
38. K. Sparbier, S. Koch, T. Wenzel, M. Kostrzewa, Selective Isolation of glycoproteins and glycopeptides for maldi-tof ms detection supported by magentic particles. Journal of Biomolecular Techniques 16 (2005), 407-413.
39. S. Tao, Y. Li, J. Zhou, J. Qian, R.L. Schnaar, Y. Zhang, I.J. Goldstein, H. Zhu, J.P. Schneck, Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers. Glycobiology 18 (2008), 761-769.
40. T.T. Thanh, N.T.M Phuong, N.B. Nhi, P.V. Chi, Changes of glycoproteins in lung cancer patients. J Proteomics Bioinform 1 (2008), 11-16.
41. K. Ueda, Y. Fukase, T. Katagiri, N. Ishikawa, S. Irie, T. Sato, H. Ito, H. Nakayama, Y. Miyagi, E. Tsuchiya, N. Kohno, M. Shiwa, Y. Nakamura, Y. Daigo, Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays. Proteomics 9 (2009), 2182-2192.
42. Y. Wang, X. Ao, H. Vuong, M. Konanur, F.R. Miller, S. Goodison, D.M. Lubman, Membrane glycoproteins associated with breast tumor cell progression identified by a lectin affinity approach. Journal of Proteome Research 7 (2008), 4313-4325.
43. M. Yodoshi, T. Oyama, K. Masaki, K. Kakehi, T. Hayakawa, S. Suzuki, Affinity entrapment of oligosaccharides and glycopeptides using free lectin solution. Analytical Sciences 27 (2011), 395-400.
44. Z. Zeng, M. Hincapie, S.J. Pitteri, S. Hanash, J. Schalkwijk, J.M. Hogan, H. Wang, W.S. Hancock, A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome. Anal Chem 83 (2011), 4845-4854.
45. L. Zhang, H. Lu, P. Yang, Specific enrichment methods for glycoproteome research. Anal Bioanal Chem 396 (2010), 199-203.
46. J. Zhao, D.M. Simeone, D. Heldt, M.A. Anderson, D.M. Lubman, Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum. Journal of Proteome Research 5 (2006), 1792-1802.